In 10 seconds? Obesity is a growing cause of cancer around the world. Researchers are uncovering how extra body fat facilitates cancer growth, so they can figure out how to best treat these cancers. Yeah…I've heard it so many...
In 10 seconds? Excess body weight is a growing cause of cancer worldwide. The number of these cancers increased 34% in the last decade! Scientists are working to better understand this issue and come up with solutions. I guess th...
In 10 seconds? Pancreatic cancer has proven to be resistant to the new cancer immunotherapies that have helped patients with other types of cancers. Some scientists think pancreatic cancer prevention may be the key to a larger can...
In 10 seconds? Cancer patients with rare cancers could finally benefit from tailored treatment decisions, or ‘precision oncology,’ thanks to genetic testing for hereditary traits. What do you mean by hereditary traits? The geneti...
In 10 seconds? Cancer care for pregnant patients is impacted by abortion limiting legislation in some US states–making patient-centered shared decision-making about cancer treatments less attainable....
In 10 seconds? Scientists are engineering immune cells called macrophages to kill cancer with the hope that these ‘living drugs’ will outperform CAR-T cells in attacking solid tumors. Could you remind me what these CAR-T treatmen...
In 10 seconds? Immune cells called myeloid cells are garnering interest for their multiple roles in both cancer formation and treatment. Research is actively unraveling the many nuances of this diverse cell population and designin...
In 10 seconds? Lymphoma patients with healthy levels of vitamin D seem to respond better to cancer treatments than those with below healthy levels. If results like these hold up in larger studies, it will mean that cancer patients...
In 10 seconds? Emerging cancer treatments, in general, are performing better in phase 1 clinical trials these days than they have historically. These findings will hopefully encourage cancer patients to participate in early trials...